Consolidated Statements of Stockholders' Deficit - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balances at Dec. 31, 2023	$ 361	$ 276,393	$ (308,819)	$ (32,065)
Balances (in shares) at Dec. 31, 2023	36,122,932
Exercise of stock options	$ 1	129		130
Exercise of stock options (in shares)	37,282
Withholdings for taxes related to net share settlement of equity awards, shares	(4,222)
Issuance of Common Stock upon release of restricted stock units, net of tax withholdings		(61)		(61)
Issuance of Common Stock upon release of restricted stock units, net of tax withholdings (In shares)	27,075
Stock-based compensation expense		2,893		2,893
Net loss			(18,916)	(18,916)
Balances at Dec. 31, 2024	$ 362	279,354	(327,735)	(48,019)
Balances (in shares) at Dec. 31, 2024	36,183,067
Exercise of stock options	$ 2	656		$ 658
Exercise of stock options (in shares)	201,602			201,602
Issuance of Common Stock upon release of restricted stock units, net of tax withholdings		(46)		$ (46)
Issuance of Common Stock upon release of restricted stock units, net of tax withholdings (In shares)	46,775
Stock-based compensation expense		2,610		2,610
Net loss			(173,799)	(173,799)
Balances at Dec. 31, 2025	$ 364	$ 282,574	$ (501,534)	$ (218,596)
Balances (in shares) at Dec. 31, 2025	36,431,444